Mouse Anti-Procainamide Antibody (MOFAB-081W)


Cat: MOFAB-081W
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

  • Product List
  • Specifications
  • Application Information
  • Target
Sub Cat Clonality Species Reactivity Application Clone Conjugate Size  
MOFAB-081W Monoclonal ELISA WPC10 100 µg
Inquiry
MOFAB-082W Monoclonal ELISA WPC12 100 µg
Inquiry
MOFAB-083W Monoclonal ELISA WPC10 100 µg
Inquiry

Specifications

Host speciesMouse
CloneWPC10
SpecificityThese antibodies recognize procainamide and cross-react to varying degrees with N-acetyl procainamide.
ImmunogenProcainamide conjugated to KLH via proprietary chemistry.
FormatLiquid or Lyophilized
BufferPBS, pH 7.4
Regulatory StatusFor Research Use Only
ShippingGel Pack
StorageStore at 4°C: short-term (1-2weeks)
Store at -20°C: long-term and future use
PurificationPEG-purified

Application Information

ApplicationELISA
Application NotesThe optimal dilution should be determined by the end user.

Target

IntroductionProcainamide is an antiarrhythmic drug used to treat cardiac arrhythmias. It induces rapid blockade of batfish toxin (BTX)-activated sodium channels in the myocardium and acts as a long-gated closure antagonist. Procainamide is metabolized through different pathways. The most common one is the acetylation of procainamide to the less toxic N-acetyl procainamide. Procainamide was approved by the US FDA on June 2, 1950.
Product OverviewThe Procainamide antibody is used as Drug antibodies.
Alternative NamesProcainamide; Procainamide
For Research Use Only | Not For Clinical Use.
Online Inquiry